BLCO — Bausch & Lomb Corp
Price · 2024-08-26 → 2026-08-21
499 daily closes shownAnonymous view is capped at two years of history. A free account extends it to five, and Pro opens the whole archive back to 2022-05-06.
Performance
Technicals
Others in Healthcare
Measured signals that fired on BLCO
| date | signal | measured base rate |
|---|---|---|
| 2026-08-19 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-07-07 | Equal highs taken out structure | -0.70% over 21 days · t = -8.28 · n = 68,636 statistically distinguishable from its control group |
| 2026-06-17 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
| 2026-03-13 | Equal lows taken out structure | -0.64% over 21 days · t = -4.75 · n = 55,661 statistically distinguishable from its control group |
Excess return against a matched control group, on a point-in-time universe that includes delisted companies. Most families do not survive that. How the measurement works →
Insider transactions (Form 4)
| date | insider | what | shares | price | value |
|---|---|---|---|---|---|
| 2026-08-12 | Chersi Robert J Director | Grant or award | 11.8K | 0.00 | 0 |
| 2026-08-12 | Trebbi Barbara Director | Grant or award | 11.8K | 0.00 | 0 |
| 2026-08-12 | PAUL LAURENCE E Director | Grant or award | 11.8K | 0.00 | 0 |
| 2026-08-10 | Munsch Frederick SVP, Controller and CAO | Open-market sale | 52.9K | 16.78 | 887.7K |
| 2026-08-07 | VON ESCHENBACH ANDREW C. Director | Open-market sale | 6.1K | 16.58 | 100.5K |
| 2026-08-06 | VON ESCHENBACH ANDREW C. Director | Open-market sale | 12.5K | 16.50 | 206.2K |
| 2026-08-05 | SAUNDERS BRENT L Chairman of the Board and CEO | Shares withheld for tax | 4.2K | 16.76 | 70.9K |
| 2026-08-05 | Bonnefoy Luc President, Surgical | Grant or award | 16.8K | 0.00 | 0 |
| 2026-08-05 | SAUNDERS BRENT L Chairman of the Board and CEO | Grant or award | 281.9K | 0.00 | 0 |
| 2026-08-05 | Bailey A Robert D EVP & Chief Legal Officer | Grant or award | 33.6K | 0.00 | 0 |
Open-market purchases (code P) are the informative ones. Grants, option exercises and tax withholding are compensation mechanics, not decisions. How to read a Form 4 →
Largest institutional holders
| manager | value | shares |
|---|---|---|
| DEUTSCHE BANK AG\ | 56.1M | 3.5M |
| ICAHN CARL C | 55.6M | 3.5M |
| OAKTREE CAPITAL MANAGEMENT LP | 53.8M | 3.4M |
| D. E. Shaw & Co., Inc. | 50.1M | 3.2M |
| GOLDENTREE ASSET MANAGEMENT LP | 42.2M | 2.7M |
| Silver Point Capital L.P. | 35.7M | 2.2M |
| Davidson Kempner Capital Management LP | 35.0M | 2.2M |
| CASPIAN CAPITAL LP | 31.8M | 2.0M |
| GLENVIEW CAPITAL MANAGEMENT, LLC | 30.4M | 1.9M |
| NOMURA HOLDINGS INC | 20.0M | 1.3M |
13F positions as of 2026-03-31, filed up to 45 days after quarter end. Long-only US equity — shorts and derivatives never appear. What 13F does and does not show →
Short selling
This is off-exchange short volume, not short interest: it is flow, not position, and 40–50% is normal because market makers short to fill your buy. Why that number misleads →
Recent headlines
- Bausch & Lomb Corp (BLCO) filed form 8-K/A · 2026-08-12 · SEC EDGAR
- Why Bausch Health Companies Stock Skyrocketed by Almost 40% Last Month · 2026-08-10
Ask the AI about BLCO
The assistant reads every block on this page — price history, filings, insider transactions, institutional positions, short volume, macro and the measured base rates — and says what it implies, quoting the number behind each claim and declaring what it does not have.
Everything on this page is live in the terminal.
Charts, filings, insider flow and the AI — open without an account.
Free plan for good. Pro is $69.99/mo, or $4.99 for a 7-day trial. See the plans →